早期治疗并接受支持使用抗TNF-α疗法治疗白塞氏葡萄膜炎的证据。 - Suppr

Suppr

超能文献

Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.

作者信息

Lee Richard W J, Dick Andrew D

出版信息

Br J Ophthalmol. 2010 Mar;94(3):269-70. doi: 10.1136/bjo.2009.176750.

DOI:10.1136/bjo.2009.176750

PMID:20215370

Abstract

摘要

相似文献

Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.

Br J Ophthalmol. 2010 Mar;94(3):269-70. doi: 10.1136/bjo.2009.176750.

Anti-TNF-alpha therapy for uveitis: Behçet and beyond.

Eye (Lond). 2005 Aug;19(8):831-3. doi: 10.1038/sj.eye.6701792.

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.

The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.

Adv Exp Med Biol. 2003;528:557-9. doi: 10.1007/0-306-48382-3_112.

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.

Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.

J Rheumatol. 2005 Aug;32(8):1633; author reply 1634.

Effect of infliximab on refractory uveitis in Behcet's disease.

Ann Pharmacother. 2004 May;38(5):901-2. doi: 10.1345/aph.1D361. Epub 2004 Mar 9.

Adalimumab for sight-threatening uveitis in Behçet's disease.

Eye (Lond). 2007 Jun;21(6):824-5. doi: 10.1038/sj.eye.6702352. Epub 2006 Apr 7.

Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.

Ann N Y Acad Sci. 2007 Sep;1110:474-84. doi: 10.1196/annals.1423.050.

引用本文的文献

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome.

Intest Res. 2015 Apr;13(2):166-9. doi: 10.5217/ir.2015.13.2.166. Epub 2015 Apr 27.

Autoimmune and autoinflammatory mechanisms in uveitis.

Semin Immunopathol. 2014 Sep;36(5):581-94. doi: 10.1007/s00281-014-0433-9. Epub 2014 May 24.

Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.

Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):633-40. doi: 10.1007/s00417-013-2552-8. Epub 2013 Dec 24.

Current and future treatments for Behçet's uveitis: road to remission.

Int Ophthalmol. 2014 Apr;34(2):365-81. doi: 10.1007/s10792-013-9788-5. Epub 2013 Jun 1.

Systemic therapies for inflammatory eye disease: past, present and future.

BMC Ophthalmol. 2013 Apr 24;13:18. doi: 10.1186/1471-2415-13-18.

Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Prog Retin Eye Res. 2012 Mar;31(2):182-94. doi: 10.1016/j.preteyeres.2011.11.004. Epub 2011 Nov 22.

Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Eye (Lond). 2012 Jan;26(1):17-28. doi: 10.1038/eye.2011.255. Epub 2011 Sep 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验